GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma

NCT05242146 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

CNS Lymphoma

Interventions

DRUG: GB5121

Sponsor

GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.